ResMed Inc. (NYSE: RMD) is -0.07% lower on its value in year-to-date trading and has touched a low of $189.40 and a high of $262.38 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RMD stock was last observed hovering at around $208.55 in the last trading session, with the day’s loss setting it -0.56% off its average median price target of $256.94 for the next 12 months. It is also 25.72% off the consensus price target high of $280.00 offered by 22 analysts, but current levels are 4.79% higher than the price target low of $218.45 for the same period.
Currently trading at $207.99, the stock is -2.60% and -4.57% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.74 million and changing -0.27% at the moment leaves the stock -5.59% off its SMA200. RMD registered -12.08% loss for a year compared to 6-month loss of -11.36%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The stock witnessed a -3.35% gain in the last 1 month and extending the period to 3 months gives it a -5.84%, and is -3.09% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.27% over the week and 1.70% over the month.
ResMed Inc. (RMD) has around 8160 employees, a market worth around $31.49B and $3.76B in sales. Current P/E ratio is 37.81 and Fwd P/E is 28.53. Profit margin for the company is 21.50%. Distance from 52-week low is 9.82% and -20.73% from its 52-week high. The company has generated returns on investments over the last 12 months (19.80%).
ResMed Inc. (RMD) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for ResMed Inc. (RMD) is a “Overweight”. 22 analysts offering their recommendations for the stock have an average rating of 2.20, where 6 rate it as a Hold and 4 think it is a “Overweight”. 12 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
ResMed Inc. is expected to release its quarterly report on 04/27/2023.The EPS is expected to grow by 63.60% this year
ResMed Inc. (RMD) Top Institutional Holders
The shares outstanding are 146.70M, and float is at 144.57M with Short Float at 0.75%.
ResMed Inc. (RMD) Insider Activity
A total of 67 insider transactions have happened at ResMed Inc. (RMD) in the last six months, with sales accounting for 41 and purchases happening 26 times. The most recent transaction is an insider sale by PENDARVIS DAVID, the company’s Chief Administrative Officer. SEC filings show that PENDARVIS DAVID sold 1,500 shares of the company’s common stock on Mar 03 at a price of $216.69 per share for a total of $0.33 million. Following the sale, the insider now owns 94172.0 shares.
ResMed Inc. disclosed in a document filed with the SEC on Mar 03 that Ghoshal Kaushik (President, SaaS Business) sold a total of 1,000 shares of the company’s common stock. The trade occurred on Mar 03 and was made at $220.00 per share for $0.22 million. Following the transaction, the insider now directly holds 15704.0 shares of the RMD stock.
Still, SEC filings show that on Feb 17, Sandercock Brett (Chief Financial Officer) disposed off 10,000 shares at an average price of $215.22 for $2.15 million. The insider now directly holds 106,880 shares of ResMed Inc. (RMD).
ResMed Inc. (RMD): Who are the competitors?
The company’s main competitors (and peers) include Five Point Holdings LLC (FPH) that is trading -65.06% down over the past 12 months and DENTSPLY SIRONA Inc. (XRAY) that is -21.98% lower over the same period.